Developer docs
API playgroundTry for free, no card

Search company profiles

TopGum Industries

Full company profile

uuid0007l7p

Namestring
TopGum Industries
Legal namestring
TopGum Industries Ltd.
Company typeenum
Public
Founded yearint
2005
Descriptiontext

TopGum Industries Ltd. is an Israeli B2B contract development and manufacturing organization (CDMO) specializing in functional gummy supplements for nutraceutical brands, pharmaceutical companies, and major retailers. Founded in 2004/2005 and listed on the Tel Aviv Stock Exchange (TASE:1943 / TLV:TPGM), the company operates from Sderot, Israel with manufacturing facilities across two continents — a new Sderot facility launched in 2025, a 65,000 sq ft facility on Prince Edward Island, Canada acquired through Island Abbey Nutritionals (March 2025), and the first U.S.-based FDA-compliant manufacturing platform acquired from P&L Developments (May 2026, up to $35M consideration).

The company's core technology is a proprietary gummy formulation and manufacturing platform built on three pillars: the Gummiceuticals Sugar-Free Matrix (a patented prebiotic fiber-based delivery system using fructooligosaccharide/FOS), TopCaps MicroEncapsulation (preserves ingredient integrity and masks challenging flavors), and a High Dose Platform enabling high active-ingredient loading without compromising taste or texture. These underpin five product categories — Women's Health, Beauty From Within (nutricosmetics), Gut Health (pre/pro/postbiotics), Immune Shield, and Active Lifestyle (electrolyte, creatine, hydration, magnesium, recovery gummies) — offered through custom, white-label, and private-label manufacturing.

TopGum generates revenue through manufacturing fees under multi-year B2B contracts with quote-based pricing. FY2025 revenue mix was 77% nutrition supplements ($78.1M, ~109% YoY growth). A strategic supply agreement with a major unnamed U.S. brand exceeded $25M through 2026. Pharmaceutical-grade gummies from the FDA-compliant U.S. platform are targeted for commercial launch in 2027-2028. FY2025 revenue was $100.95M (~70% YoY growth) with $15.7M Adjusted EBITDA; Q1 2026 revenue reached $31.9M (+85% YoY) with a record $52M order backlog, signaling continued strong momentum.

Short descriptiontext

TopGum Industries is an Israeli B2B CDMO (contract development and manufacturing organization) producing functional gummy supplements — including women's health, beauty, gut health, and sports nutrition — for nutraceutical brands, pharmaceutical companies, and major retailers, using proprietary sugar-free matrix and microencapsulation technologies across manufacturing facilities in Israel, Canada, and the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSderot, Israel
HQ citystring
Sderot
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gummy contract manufacturing, nutraceutical CDMO services, white-label supplements, pharmaceutical gummy manufacturing, dietary supplement manufacturing
Industry1 code
PRIMARYAFAKAAAD
Confectionery Manufacturing (Chocolate, Candy, Gum)
NAICS code1 code
  • Nonchocolate Confectionery Manufacturing311340
SIC code1 code
  • Sugar & Confectionery Products2060
Product category
Nutraceutical Contract Manufacturing
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Manufacturing (B2B/CDMO)
TypeOne Time License
Description

Contract development and manufacturing services for dietary supplement brands, pharmaceutical companies, and retailers. Generates revenue through manufacturing fees for white-label and private-label gummy supplement production. Revenue mix includes nutrition supplements (77% of 2025 revenue), with pharmaceutical gummy products targeted for commercial launch in 2027-2028.

tgum.com
2Supply Agreements
TypeTransaction Fee
Description

Strategic supply agreements with major U.S. brands for supplement manufacturing. Example: $25 million+ supply agreement through 2026 with major U.S. brand. Revenue recognized from product shipments under multi-year contracts.

ynetnews.com
3Pharmaceutical Gummy Manufacturing
TypeOne Time License
Description

Pharmaceutical gummy manufacturing revenue from U.S. FDA-compliant operations. Expected to generate revenue starting 2026-2027 under major unnamed pharmaceutical partner's brands. Revenue model based on manufacturing fees for pharmaceutical-grade products.

prnewswire.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1B2B contract manufacturing pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed - custom formulations and manufacturing services priced per project and volume requirements

tgum.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

TopGum Industries is a contract development and manufacturing organization (CDMO) that produces custom, white-label, and private-label functional gummy supplements for nutraceutical brands, pharmaceutical companies, and retailers. The company manufactures gummy products across five categories (Women's Health, Beauty From Within, Gut Health, Immune Shield, Active Lifestyle) using proprietary technologies including a patented sugar-free prebiotic fiber matrix, microencapsulation, and high-dose active ingredient delivery platforms. Manufacturing operations span facilities in Israel, Canada, and the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 162% surge in dietary supplements segment revenue in Q1 2026 year-over-year
+4 more records
Product overview1 text field

TopGum Industries is a gummy supplement contract manufacturer and technology provider offering a portfolio of proprietary technology platforms (Gummiceuticals Sugar-Free Matrix, TopCaps MicroEncapsulation, High Dose Platform) and five product categories: Women's Health, Beauty From Within, Gut Health, Immune Shield, and Active Lifestyle. The company provides custom, white-label, and private-label gummy supplements through its manufacturing facilities across two continents, leveraging specialized technologies for sugar-free formulations, microencapsulation, and high-dose active delivery. Product offerings span botanical women's wellness gummies (Shatavari), beauty-from-within nutricosmetic formulations (HSN+, hyaluronic acid, collagen), hydration gummies (electrolyte), sports nutrition products (creatine, magnesium, recovery), and pre-/pro-/postbiotic digestive health formulas.

Product and service8 records
1Women's Health Gummies
CategoryWomen's Health Functional Supplements
Description

Tailor-made women's health gummy supplements supporting women through every life stage, from fertility and pregnancy to postpartum recovery and menopause, delivered via proprietary Gummiceuticals Sugar-Free Matrix technology.

2Beauty From Within Gummies
CategoryNutricosmetics
Description

Beauty-from-within nutricosmetic gummies featuring HSN+ (hair, skin, nails), hyaluronic acid, and collagen formulations designed to enhance inner radiance with proprietary Gummiceuticals technology.

3Gut Health Gummies
CategoryDigestive Health Supplements
Description

Digestive health gummies addressing the rising demand for digestive health with innovative, easy-to-take supplement formats supporting nutrient absorption, immune function, mood, and energy levels. Includes pre-, pro-, and postbiotic formulas.

4Immune Shield Gummies
CategoryImmune Health Supplements
Description

Immune support gummies formulated to fortify the body's natural defenses with essential nutrients against daily health challenges.

5Active Lifestyle Gummies
CategorySports Nutrition / Active Lifestyle Supplements
Description

Expertly crafted active lifestyle formulations enhancing energy, endurance, strength, and recovery, including electrolyte, creatine, energy, magnesium, and recovery gummies — providing convenient alternatives to traditional shakes, gels, and powders.

6High-Dose Electrolyte / Hydration Gummies
CategoryHydration / Electrolyte Supplements
Description

High-dose electrolyte / hydration gummies formulated with proprietary fiber matrix technology incorporating fructooligosaccharide (FOS) and encapsulation techniques for bioactives, addressing high sugar content and low active ingredient payload challenges in hydration and electrolyte gummies.

7Contract Manufacturing & White-Label CDMO Services
CategoryContract Development & Manufacturing (CDMO)
Description

Custom, white-label, and private-label gummy supplement contract development and manufacturing services for dietary supplement brands, pharmaceutical companies, and retailers. Includes formulation R&D, manufacturing, and packaging solutions (bottles, sachets, pouches, on-the-go formats).

8FDA Pharmaceutical-Compliant Gummy Manufacturing
CategoryPharmaceutical CDMO Services
Description

FDA pharmaceutical-compliant manufacturing for pharmaceutical partners producing gummy-formulated medications and supplements under major pharmaceutical partner brands. Provides FDA 21 CFR Part 11 compliant manufacturing capabilities with integration expected through 2026.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-05
Description

TopGum completed acquisition of P&L Developments' U.S. gummy manufacturing operations for up to $35 million ($10M cash, ~$8M shares, up to $17M contingent consideration). The transaction gives TopGum its first U.S.-based FDA pharmaceutical-compliant manufacturing platform. In return, PLD gains privileged access to distribute TopGum products to major U.S. retailers under store-brand labels.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-05
Description

Strategic commercial partnership through which PLD distributes TopGum products to major U.S. retailers under store-brand labels, expanding TopGum's presence in primary target market.

3Unnamed Major Pharmaceutical Partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-09
Description

Strategic partnership for pharmaceutical gummy products expected to begin commercial launch in 2027-2028 under major unnamed pharmaceutical partner's brands. Represents TopGum's entry into pharmaceutical gummy sector.

nutraceuticalsworld.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-01
Description

TopGum acquired Island Abbey Nutritionals, a contract development and manufacturing organization (CDMO) specializing in gummy and lozenge supplements located on Prince Edward Island, Canada. The acquisition expanded TopGum's manufacturing capabilities in North America with a 65,000 sq ft facility featuring starchless depositing, center-fill capabilities, and automated bottling and packaging lines.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-10-01
Description

GOOM, a vegan and sugar-free gummy supplement startup founded by Israeli paratroopers, partnered with TopGum to produce their supplements after being rejected by multiple Israeli factories. GOOM achieved 1,200% sales growth in early 2026 with tens of millions of shekels in revenue.

6PharmItBe, Ltd.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-20
Description

TopGum acquired PharmItBe, an FDA-certified analytical laboratory, to enhance pharma-grade gummy development, improve supply chain efficiency, and expand analytical capabilities. The acquisition included appointment of Dr. Evgenia Lozinsky as Head of R&D. A new facility supported by $40 million investment was planned to open by year-end 2023.

prnewswire.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
1Procaps Group
TypeDirect peer
Description

Colombian-headquartered, NYSE-listed CDMO with softgel and gummy supplement manufacturing serving global nutraceutical brands. Closest publicly traded peer to TopGum by business model (B2B contract manufacturing of gummy/softgel supplements), customer base (nutraceutical brands), and geographic model (manufacturing in lower-cost regions serving U.S./global demand).

TypeDirect peer
Description

U.S.-based contract manufacturer of liquid, powder, tablet, and gummy dietary supplements serving nutraceutical brands. Comparable B2B CDMO model in adjacent product formats to TopGum.

TypeDirect peer
Description

U.S.-based contract manufacturer specializing in softgel and gummy supplement production for dietary supplement and OTC brands. Directly comparable CDMO model with gummy manufacturing as a core capability.

4Best Formulations
TypeDirect peer
Description

U.S.-based nutraceutical contract manufacturer offering gummy, softgel, tablet, and capsule capabilities for dietary supplement brands. Comparable CDMO model serving the same U.S. brand customers TopGum targets.

TypeBroad incumbent
Description

Major global CDMO (now owned by Novo Holdings) offering softgel, gummy, and oral dose manufacturing for pharmaceutical and consumer health customers. A much larger incumbent with broader capabilities, but operates in the same contract manufacturing space TopGum is moving into for pharmaceutical gummies.

TypeDirect peer
Description

U.S.-headquartered contract manufacturer specializing in gummy dietary supplements for nutraceutical brands. Direct peer in gummy CDMO space with similar customer profile and product format focus.

TypeDirect peer
Description

China-based global nutraceutical CDMO with explicit gummy supplement manufacturing capabilities serving brand customers across North America, Europe, and Asia. Highly comparable B2B contract manufacturing model targeting the same dietary supplement end-market as TopGum.

TypeBroad incumbent
Description

Swiss-listed global CDMO with consumer health and nutrition capabilities including gummy formats. Operates in the same end-markets as TopGum but at much larger scale and across a far broader portfolio of dosage forms.

TypeBroad incumbent
Description

European-headquartered CDMO serving pharmaceutical and nutraceutical customers with solid, semi-solid, and oral dose forms including gummies. Larger incumbent with overlapping capabilities to TopGum, particularly relevant for European customer acquisition.

TypeDirect peer
Description

U.S.-based nutraceutical and OTC pharmaceutical CDMO with capabilities in gummy, softgel, tablet, and capsule manufacturing. Comparable CDMO model targeting similar dietary supplement and pharmaceutical customer segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TopGum Industries

Nutraceutical Contract Manufacturingtopgummiceuticals.com

TopGum Industries is an Israeli B2B CDMO (contract development and manufacturing organization) producing functional gummy supplements — including women's health, beauty, gut health, and sports nutrition — for nutraceutical brands, pharmaceutical companies, and major retailers, using proprietary sugar-free matrix and microencapsulation technologies across manufacturing facilities in Israel, Canada, and the United States.

What TopGum Industries does

TopGum Industries Ltd. is an Israeli B2B contract development and manufacturing organization (CDMO) specializing in functional gummy supplements for nutraceutical brands, pharmaceutical companies, and major retailers. Founded in 2004/2005 and listed on the Tel Aviv Stock Exchange (TASE:1943 / TLV:TPGM), the company operates from Sderot, Israel with manufacturing facilities across two continents — a new Sderot facility launched in 2025, a 65,000 sq ft facility on Prince Edward Island, Canada acquired through Island Abbey Nutritionals (March 2025), and the first U.S.-based FDA-compliant manufacturing platform acquired from P&L Developments (May 2026, up to $35M consideration).

The company's core technology is a proprietary gummy formulation and manufacturing platform built on three pillars: the Gummiceuticals Sugar-Free Matrix (a patented prebiotic fiber-based delivery system using fructooligosaccharide/FOS), TopCaps MicroEncapsulation (preserves ingredient integrity and masks challenging flavors), and a High Dose Platform enabling high active-ingredient loading without compromising taste or texture. These underpin five product categories — Women's Health, Beauty From Within (nutricosmetics), Gut Health (pre/pro/postbiotics), Immune Shield, and Active Lifestyle (electrolyte, creatine, hydration, magnesium, recovery gummies) — offered through custom, white-label, and private-label manufacturing.

TopGum generates revenue through manufacturing fees under multi-year B2B contracts with quote-based pricing. FY2025 revenue mix was 77% nutrition supplements ($78.1M, ~109% YoY growth). A strategic supply agreement with a major unnamed U.S. brand exceeded $25M through 2026. Pharmaceutical-grade gummies from the FDA-compliant U.S. platform are targeted for commercial launch in 2027-2028. FY2025 revenue was $100.95M (~70% YoY growth) with $15.7M Adjusted EBITDA; Q1 2026 revenue reached $31.9M (+85% YoY) with a record $52M order backlog, signaling continued strong momentum.

TopGum Industries firmographics

Firmographics
Name
TopGum Industries
Legal name
TopGum Industries Ltd.
Website
https://topgummiceuticals.com
Company type
Public
Founded year
2005
Operating status
Operating
Headcount range
101–250 employees
Short description
TopGum Industries is an Israeli B2B CDMO (contract development and manufacturing organization) producing functional gummy supplements — including women's health, beauty, gut health, and sports nutrition — for nutraceutical brands, pharmaceutical companies, and major retailers, using proprietary sugar-free matrix and microencapsulation technologies across manufacturing facilities in Israel, Canada, and the United States.
Ownership category
akta.pro rank

TopGum Industries industry classification

Industry
Product category
Nutraceutical Contract Manufacturing
NAICS
Nonchocolate Confectionery Manufacturing (311340)
SIC
Sugar & Confectionery Products (2060)
akta.pro industry
PRIMARYAFAKAAAD
Confectionery Manufacturing (Chocolate, Candy, Gum)

Keywords

  • Gummy contract manufacturing
  • Nutraceutical CDMO services
  • White-label supplements
  • Pharmaceutical gummy manufacturing
  • Dietary supplement manufacturing

Where TopGum Industries is headquartered

Location

Headquarters

HQ city
Sderot
HQ country
Israel
HQ region
Middle East

Offices4 records

Markets served

TopGum Industries business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Manufacturing (B2B/CDMO): Contract development and manufacturing services for dietary supplement brands, pharmaceutical companies, and retailers. Generates revenue through manufacturing fees for white-label and private-label gummy supplement production. Revenue mix includes nutrition supplements (77% of 2025 revenue), with pharmaceutical gummy products targeted for commercial launch in 2027-2028.
  2. Supply Agreements: Strategic supply agreements with major U.S. brands for supplement manufacturing. Example: $25 million+ supply agreement through 2026 with major U.S. brand. Revenue recognized from product shipments under multi-year contracts.
  3. Pharmaceutical Gummy Manufacturing: Pharmaceutical gummy manufacturing revenue from U.S. FDA-compliant operations. Expected to generate revenue starting 2026-2027 under major unnamed pharmaceutical partner's brands. Revenue model based on manufacturing fees for pharmaceutical-grade products.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B contract manufacturing pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

TopGum Industries product offering

Product offering

Core offering

TopGum Industries is a contract development and manufacturing organization (CDMO) that produces custom, white-label, and private-label functional gummy supplements for nutraceutical brands, pharmaceutical companies, and retailers. The company manufactures gummy products across five categories (Women's Health, Beauty From Within, Gut Health, Immune Shield, Active Lifestyle) using proprietary technologies including a patented sugar-free prebiotic fiber matrix, microencapsulation, and high-dose active ingredient delivery platforms. Manufacturing operations span facilities in Israel, Canada, and the United States.

Product overview

TopGum Industries is a gummy supplement contract manufacturer and technology provider offering a portfolio of proprietary technology platforms (Gummiceuticals Sugar-Free Matrix, TopCaps MicroEncapsulation, High Dose Platform) and five product categories: Women's Health, Beauty From Within, Gut Health, Immune Shield, and Active Lifestyle. The company provides custom, white-label, and private-label gummy supplements through its manufacturing facilities across two continents, leveraging specialized technologies for sugar-free formulations, microencapsulation, and high-dose active delivery. Product offerings span botanical women's wellness gummies (Shatavari), beauty-from-within nutricosmetic formulations (HSN+, hyaluronic acid, collagen), hydration gummies (electrolyte), sports nutrition products (creatine, magnesium, recovery), and pre-/pro-/postbiotic digestive health formulas.

Differentiator

Problem solved

Functional benefit

Products and services

  • Women's Health Gummies Tailor-made women's health gummy supplements supporting women through every life stage, from fertility and pregnancy to postpartum recovery and menopause, delivered via proprietary Gummiceuticals Sugar-Free Matrix technology.
  • Beauty From Within Gummies Beauty-from-within nutricosmetic gummies featuring HSN+ (hair, skin, nails), hyaluronic acid, and collagen formulations designed to enhance inner radiance with proprietary Gummiceuticals technology.
  • Gut Health Gummies Digestive health gummies addressing the rising demand for digestive health with innovative, easy-to-take supplement formats supporting nutrient absorption, immune function, mood, and energy levels. Includes pre-, pro-, and postbiotic formulas.
  • Immune Shield Gummies Immune support gummies formulated to fortify the body's natural defenses with essential nutrients against daily health challenges.
  • Active Lifestyle Gummies Expertly crafted active lifestyle formulations enhancing energy, endurance, strength, and recovery, including electrolyte, creatine, energy, magnesium, and recovery gummies — providing convenient alternatives to traditional shakes, gels, and powders.
  • High-Dose Electrolyte / Hydration Gummies High-dose electrolyte / hydration gummies formulated with proprietary fiber matrix technology incorporating fructooligosaccharide (FOS) and encapsulation techniques for bioactives, addressing high sugar content and low active ingredient payload challenges in hydration and electrolyte gummies.
  • Contract Manufacturing & White-Label CDMO Services Custom, white-label, and private-label gummy supplement contract development and manufacturing services for dietary supplement brands, pharmaceutical companies, and retailers. Includes formulation R&D, manufacturing, and packaging solutions (bottles, sachets, pouches, on-the-go formats).
  • FDA Pharmaceutical-Compliant Gummy Manufacturing FDA pharmaceutical-compliant manufacturing for pharmaceutical partners producing gummy-formulated medications and supplements under major pharmaceutical partner brands. Provides FDA 21 CFR Part 11 compliant manufacturing capabilities with integration expected through 2026.

Quantifiable outcome

  • 162% surge in dietary supplements segment revenue in Q1 2026 year-over-year
  • +4 more outcomes

Companies that use TopGum Industries

Customer profile

Named customers2 records

Segments6 records

Ideal customer profiles3 records

TopGum Industries technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

TopGum Industries partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • P&L Developments LLCcoreStrategic or Co-development Partner · 5 May 2026TopGum completed acquisition of P&L Developments' U.S. gummy manufacturing operations for up to $35 million ($10M cash, ~$8M shares, up to $17M contingent consideration). The transaction gives TopGum its first U.S.-based FDA pharmaceutical-compliant manufacturing platform. In return, PLD gains privileged access to distribute TopGum products to major U.S. retailers under store-brand labels.
  • Major U.S. RetailerscoreChannel Partner/ Reseller/ Distributor · 5 May 2026Strategic commercial partnership through which PLD distributes TopGum products to major U.S. retailers under store-brand labels, expanding TopGum's presence in primary target market.
  • Unnamed Major Pharmaceutical PartnercoreStrategic or Co-development Partner · 9 February 2026Strategic partnership for pharmaceutical gummy products expected to begin commercial launch in 2027-2028 under major unnamed pharmaceutical partner's brands. Represents TopGum's entry into pharmaceutical gummy sector.
  • Island Abbey NutritionalscoreStrategic or Co-development Partner · 1 March 2025TopGum acquired Island Abbey Nutritionals, a contract development and manufacturing organization (CDMO) specializing in gummy and lozenge supplements located on Prince Edward Island, Canada. The acquisition expanded TopGum's manufacturing capabilities in North America with a 65,000 sq ft facility featuring starchless depositing, center-fill capabilities, and automated bottling and packaging lines.
  • GOOMminorChannel Partner/ Reseller/ Distributor · 1 October 2023GOOM, a vegan and sugar-free gummy supplement startup founded by Israeli paratroopers, partnered with TopGum to produce their supplements after being rejected by multiple Israeli factories. GOOM achieved 1,200% sales growth in early 2026 with tens of millions of shekels in revenue.
  • PharmItBe, Ltd.coreStrategic or Co-development Partner · 20 April 2023TopGum acquired PharmItBe, an FDA-certified analytical laboratory, to enhance pharma-grade gummy development, improve supply chain efficiency, and expand analytical capabilities. The acquisition included appointment of Dr. Evgenia Lozinsky as Head of R&D. A new facility supported by $40 million investment was planned to open by year-end 2023.

Scale indicators12 records

Recent moves8 records

Expansion highlights7 records

TopGum Industries competitors and assessment

Company assessment

Direct peers

  • Procaps Group: Colombian-headquartered, NYSE-listed CDMO with softgel and gummy supplement manufacturing serving global nutraceutical brands. Closest publicly traded peer to TopGum by business model (B2B contract manufacturing of gummy/softgel supplements), customer base (nutraceutical brands), and geographic model (manufacturing in lower-cost regions serving U.S./global demand).
  • Gemini Pharmaceuticals: U.S.-based contract manufacturer of liquid, powder, tablet, and gummy dietary supplements serving nutraceutical brands. Comparable B2B CDMO model in adjacent product formats to TopGum.
  • Captek Softgel International: U.S.-based contract manufacturer specializing in softgel and gummy supplement production for dietary supplement and OTC brands. Directly comparable CDMO model with gummy manufacturing as a core capability.
  • Best Formulations: U.S.-based nutraceutical contract manufacturer offering gummy, softgel, tablet, and capsule capabilities for dietary supplement brands. Comparable CDMO model serving the same U.S. brand customers TopGum targets.
  • Vitakem: U.S.-headquartered contract manufacturer specializing in gummy dietary supplements for nutraceutical brands. Direct peer in gummy CDMO space with similar customer profile and product format focus.
  • Sirio Pharma: China-based global nutraceutical CDMO with explicit gummy supplement manufacturing capabilities serving brand customers across North America, Europe, and Asia. Highly comparable B2B contract manufacturing model targeting the same dietary supplement end-market as TopGum.
  • Contract Pharmacal Corp: U.S.-based nutraceutical and OTC pharmaceutical CDMO with capabilities in gummy, softgel, tablet, and capsule manufacturing. Comparable CDMO model targeting similar dietary supplement and pharmaceutical customer segments.

Broad incumbents

  • Catalent: Major global CDMO (now owned by Novo Holdings) offering softgel, gummy, and oral dose manufacturing for pharmaceutical and consumer health customers. A much larger incumbent with broader capabilities, but operates in the same contract manufacturing space TopGum is moving into for pharmaceutical gummies.
  • Lonza Consumer Health & Nutrition: Swiss-listed global CDMO with consumer health and nutrition capabilities including gummy formats. Operates in the same end-markets as TopGum but at much larger scale and across a far broader portfolio of dosage forms.
  • Aenova Group: European-headquartered CDMO serving pharmaceutical and nutraceutical customers with solid, semi-solid, and oral dose forms including gummies. Larger incumbent with overlapping capabilities to TopGum, particularly relevant for European customer acquisition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

TopGum Industries social profiles

Digital presence

TopGum Industries compliance and trust

Trust signal

Compliance2 records

TopGum Industries financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TopGum Industries leadership team

Management profile

Number of profiles

Profiles5 records

TopGum Industries subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

TopGum Industries funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TopGum Industries M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TopGum Industries

What does TopGum Industries do?

TopGum Industries is a contract development and manufacturing organization (CDMO) that produces custom, white-label, and private-label functional gummy supplements for nutraceutical brands, pharmaceutical companies, and retailers. The company manufactures gummy products across five categories (Women's Health, Beauty From Within, Gut Health, Immune Shield, Active Lifestyle) using proprietary technologies including a patented sugar-free prebiotic fiber matrix, microencapsulation, and high-dose active ingredient delivery platforms. Manufacturing operations span facilities in Israel, Canada, and the United States.

Is TopGum Industries a public or private company?

TopGum Industries is a public company. It is classified as public and is currently operating.

When was TopGum Industries founded?

TopGum Industries was founded in 2005. It employs 101 to 250 people.

Where is TopGum Industries based?

TopGum Industries is headquartered in Sderot, Israel, in the Middle East region.

How does TopGum Industries make money?

Three revenue lines are on record. Contract Manufacturing (B2B/CDMO) is the primary driver. The others are supply Agreements and pharmaceutical Gummy Manufacturing.

Who are TopGum Industries's main competitors?

Direct peers on record are Procaps Group, Gemini Pharmaceuticals, Captek Softgel International, Best Formulations, Vitakem, Sirio Pharma and Contract Pharmacal Corp. Broad incumbents are Catalent, Lonza Consumer Health & Nutrition and Aenova Group.

Does TopGum Industries have an API?

No public API is recorded for TopGum Industries.

What industry is TopGum Industries in?

TopGum Industries's product category is Nutraceutical Contract Manufacturing. Its primary akta.pro industry code is AFAKAAAD, Confectionery Manufacturing (Chocolate, Candy, Gum). Its NAICS code is 311340 and its SIC code is 2060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireInfluential Women: Jennifer Toomey, Bringing Science-Driven Innovation and Team Leadership to Natural SupplementsJennifer Toomey serves as Head of New Product Development, U.S. at TopGum Industries, bringing 25 years of natural products experience. She previously led at New Chapter, Inc. and holds an MBA in Entrepreneurship. She advocates for greater inclusion of women in the industry.EIN PresswireInfluential Women: Jennifer Toomey, Bringing Science-Driven Innovation and Team Leadership to Natural SupplementsJennifer Toomey serves as Head of New Product Development, U.S. at TopGum Industries, bringing 25 years of natural products experience. She oversees product innovation, formulation, and technical teams, and holds an MBA in Entrepreneurship. She advocates for greater inclusion of women in the industry.GlobesOfra Strauss joins TopGum’s board of directorsOfra Strauss, chairperson of the Strauss Group, joined TopGum's board of directors. TopGum reported Q2 2026 revenue of about $33.8 million, up 50% organically, and expects annual sales over $145 million in H2 2026.PR NewswireTopGum Advances Longevity with Gummies for Cognition and VisionTopGum Industries unveiled a new gummy line targeting cognition and eye health, including a Focus gummy with lion's mushroom and Brahmi, and a mango gummy with trans-lutein and zeaxanthin. The company cites Innova Market Insight data showing 73% of consumers rate healthy aging as extremely or very important.Third NewsTopGum Industries Expects Significant Growth in H2 2026 Revenue with $145 Million Run RateTopGum Industries Ltd. announced projections for H2 2026, expecting an annualized revenue run rate exceeding $145 million, representing a 20% increase from the prior year's approximately $120 million. The growth is driven by deepening relationships with strategic customers and a planned product launch at Costco in the United States during Q4 2026, marking a strategic customer's shift from online-only sales to brick-and-mortar retail. The company manufactures gummy dietary supplements using its proprietary Gummiceuticals formulation at facilities in Israel, Canada, and the U.S.PR NewswireTopGum Accelerates Growth: H2 2026 Revenue to Reflect an Annualized Run Rate Exceeding $145 MillionTopGum expects H2 2026 revenue to reflect an annualized run rate exceeding $145 million, up over 20% from H2 2025. Growth is driven by expanding with existing and emerging North American customers, including a planned Costco launch in Q4 2026 that will contribute single-digit millions in 2026.Nutritional OutlookTopGum Launches Women’s Gummy Line Featuring Shatavari and Targeted BotanicalsTopGum Industries has launched a new women’s health-focused gummy product line, including a high-dose shatavari gummy with vitamin D targeting hormonal balance and menopause symptoms, with the collection unveiled ahead of Vitafoods Europe 2026. The line also includes condition-specific formulations for PMS, nausea, urinary tract health, and prenatal nutrition. The company notes the global women’s health supplement market is valued at approximately $60 billion, with a 22% year-over-year increase in sales reflecting growing demand for targeted, evidence-based nutraceutical solutions.PR NewswireTopGum Continues Its Rapid Growth Trend and Opens 2026 with Another Record QuarterTopGum Industries Ltd. reported record Q1 2026 financial results with revenues of $31.9 million, an 85% increase year-over-year, driven by a 162% surge in the dietary supplements segment. Adjusted EBITDA grew 112% to $5.3 million, and the company's order backlog reached a record $52 million for the next 4-5 months. Following the reporting period, TopGum completed the acquisition of gummy manufacturing operations in the US from P&L Developments, marking its entry into the pharmaceutical gummy sector and strengthening its presence in its primary target market.PR NewswireConcentrated Shatavari Nutraceutical Gummy Leads TopGum's New Women's CollectionTopGum Industries, a Tel Aviv-based gummy supplement manufacturer listed on TASE, unveiled a new line of seven botanical gummy formulations tailored for women's wellness across all life stages, with the SRI-81 shatavari gummy as the flagship product. The women's health supplement market is valued at approximately $60 billion, having grown 25% since 2020, with leading retailers reporting a 22% year-over-year increase in sales. The collection will be showcased at Vitafoods Europe 2026 in Barcelona and includes targeted formulations for PMS relief, nausea, urinary tract health, prenatal support, and menopause symptoms.